• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
From the coal face: the Victorian experience - Dr Keri Alexander - DrugInfo   seminar - New and emerging drugs
 

From the coal face: the Victorian experience - Dr Keri Alexander - DrugInfo seminar - New and emerging drugs

on

  • 397 views

Patients presenting with complications from new and emerging drugs are appearing in the hospital system. Currently, there is little known about how best to treat them. Presentations include requests ...

Patients presenting with complications from new and emerging drugs are appearing in the hospital system. Currently, there is little known about how best to treat them. Presentations include requests for detoxification, as well as crisis, e.g. acute psychiatric complications. No practical screening system is in place, so this is an example of how we have to adapt to the circumstances. Dr Alexander presents a case study.

Statistics

Views

Total Views
397
Views on SlideShare
276
Embed Views
121

Actions

Likes
0
Downloads
2
Comments
0

2 Embeds 121

http://www.druginfo.adf.org.au 119
http://druginfo.aws1.salsadigitalhosting.com.au 2

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    From the coal face: the Victorian experience - Dr Keri Alexander - DrugInfo   seminar - New and emerging drugs From the coal face: the Victorian experience - Dr Keri Alexander - DrugInfo seminar - New and emerging drugs Presentation Transcript

    • New & Emerging Drugs At the Coal Face: The Victorian Experience Dr Keri Alexander Addiction Medicine Specialist Turning Point Eastern Health YSAS
    • The Big Unknown • • • • Patients aren’t screened Patients / carers aren’t divulging No monitoring from the hospitals Anecdotal from professional networks eg VAILA (hospital D&A nurses and specialists) • Unknown drug content
    • What about monitoring from DACAS? • Inherently biased/ opportunistic calls • Ad hoc reporting • Nil strategic research data collection and analysis
    • How to treat ???
    • Case of SW • • • • 22yr old man 6 year history of cannabis use First two years were marijuana Past 4 years were synthetic cannabis
    • Case SW cont • Reported escalating tolerance to each brand/ product over time, relieved by switching brands • History of withdrawal symptoms, which varied between brands (possibly co-incidental) • Costs $400 per week ie $20,000 per year